{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:13:14Z","timestamp":1789913594263,"version":"4.0.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":1155,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1469-0691.2011.03610.x","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T13:32:50Z","timestamp":1308576770000},"page":"1462-1470","source":"Crossref","is-referenced-by-count":82,"title":["Visceral leishmaniasis: immunology and prospects for a vaccine"],"prefix":"10.1016","volume":"17","author":[{"given":"P.M.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Aebischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2011.03610.x_bib1","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1371\/journal.pntd.0000943","article-title":"Vaccines for the leishmaniases: proposals for a research agenda","volume":"5","author":"Costa","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/0974-777X.62881","article-title":"Leishmaniasis Vaccine: Where are We Today?","volume":"2","author":"Kedzierski","year":"2010","journal-title":"J Glob Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4161\/hv.5.5.7607","article-title":"Vaccines and vaccination strategies against human cutaneous leishmaniasis","volume":"5","author":"Okwor","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.meegid.2009.02.009","article-title":"Vaccine development againstTrypanosoma cruzi andLeishmania species in the post\u2010genomic era","volume":"9","author":"Dumonteil","year":"2009","journal-title":"Infect Genet Evol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib5","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1016\/j.vaccine.2009.05.084","article-title":"Efficacy of killed whole\u2010parasite vaccines in the prevention of leishmaniasis: a meta\u2010analysis","volume":"27","author":"Noazin","year":"2009","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second\u2010generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib8","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of theLeishmania donovani complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(04)57001-X","article-title":"Canine leishmaniasis","volume":"57","author":"Alvar","year":"2004","journal-title":"Adv Parasitol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pt.2010.04.005","article-title":"Immunity toLeishmania and the rational search for vaccines against canine leishmaniasis","volume":"26","author":"Reis","year":"2010","journal-title":"Trends Parasitol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib11","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas","volume":"27","author":"Palatnik\u2010de\u2010Sousa","year":"2009","journal-title":"Vaccine"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2011.03610.x_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-3156.2010.02519.x","article-title":"The epidemiology ofLeishmania donovani infection in high transmission foci in India","volume":"15","author":"Singh","year":"2010","journal-title":"Trop Med Int Health"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib14","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jcp.56.11.840","article-title":"Parasite detection in patients with post kala\u2010azar dermal leishmaniasis in India: a comparison between molecular and immunological methods","volume":"56","author":"Salotra","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post\u2010kala\u2010azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib16","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a cohort of brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.actatropica.2010.08.015","article-title":"Canine visceral leishmaniasis in Teresina, Brazil: relationship between clinical features and infectivity for sand flies","volume":"117","author":"Soares","year":"2011","journal-title":"Acta Trop"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetpar.2007.03.004","article-title":"Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, toLutzomyia longipalpis phlebotomine sand flies","volume":"147","author":"Michalsky","year":"2007","journal-title":"Vet Parasitol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12026-009-8135-4","article-title":"Immune evasive mechanisms contributing to persistentLeishmania donovani infection","volume":"47","author":"Stager","year":"2010","journal-title":"Immunol Res"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-777X.62876","article-title":"Immunological perspectives of leishmaniasis","volume":"2","author":"Nylen","year":"2010","journal-title":"J Glob Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib21","first-page":"412","article-title":"Immunobiology of leishmaniasis","volume":"47","author":"Sharma","year":"2009","journal-title":"Indian J Exp Biol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.0105-2896.2004.00188.x","article-title":"The immunopathology of experimental visceral leishmaniasis","volume":"201","author":"Kaye","year":"2004","journal-title":"Immunol Rev"},{"issue":"suppl 1","key":"10.1111\/j.1469-0691.2011.03610.x_bib23","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0035-9203(01)90218-4","article-title":"Leishmaniasis in Sudan. Visceral leishmaniasis","volume":"95","author":"Zijlstra","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib24","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/eji.200939455","article-title":"Murine visceral leishmaniasis: IgM and polyclonal B\u2010cell activation lead to disease exacerbation","volume":"40","author":"Deak","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib25","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.4049\/jimmunol.164.7.3681","article-title":"B cell\u2010deficient mice are highly resistant toLeishmania donovani infection, but develop neutrophil\u2010mediated tissue pathology","volume":"164","author":"Smelt","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib26","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","article-title":"Intrinsic antibody\u2010dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes","volume":"10","author":"Halstead","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib27","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.4049\/jimmunol.1002484","article-title":"IgG1 is pathogenic inLeishmania mexicana infection","volume":"185","author":"Chu","year":"2010","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virol.2010.12.016","article-title":"Contributions of humoral and cellular immunity to vaccine\u2010induced protection in humans","volume":"411","author":"Amanna","year":"2011","journal-title":"Virology"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/IAI.00338-10","article-title":"Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoanLeishmania infantum chagasi","volume":"79","author":"Thalhofer","year":"2011","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib30","doi-asserted-by":"crossref","first-page":"e1000805","DOI":"10.1371\/journal.ppat.1000805","article-title":"Dynamic imaging of experimentalLeishmania donovani\u2010induced hepatic granulomas detects Kupffer cell\u2010restricted antigen presentation to antigen\u2010specific CD8 T cells","volume":"6","author":"Beattie","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib31","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4269\/ajtmh.2006.74.1013","article-title":"Responses toLeishmania donovani in mice deficient in both phagocyte oxidase and inducible nitric oxide synthase","volume":"74","author":"Murray","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib32","doi-asserted-by":"crossref","first-page":"e1000813","DOI":"10.1371\/journal.ppat.1000813","article-title":"Innate killing ofLeishmania donovani by macrophages of the splenic marginal zone requires IRF\u20107","volume":"6","author":"Phillips","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib33","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.4049\/jimmunol.146.8.2763","article-title":"Differential production of Th1\u2010 and Th2\u2010derived cytokines does not determine the genetically controlled or vaccine\u2010induced rate of cure in murine visceral leishmaniasis","volume":"146","author":"Kaye","year":"1991","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib34","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/IAI.71.8.4804-4807.2003","article-title":"Both interleukin\u20104 (IL\u20104) and IL\u20104 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity","volume":"71","author":"Stager","year":"2003","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib35","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/eji.200635937","article-title":"Distinct roles for IL\u20106 and IL\u201012p40 in mediating protection againstLeishmania donovani and the expansion of IL\u201010+ CD4+ T cells","volume":"36","author":"Stager","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL\u201010 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nylen","year":"2007","journal-title":"J Exp Med"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib37","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/jid.2009.393","article-title":"Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post\u2010kala\u2010azar dermal leishmaniasis","volume":"130","author":"Ganguly","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/IAI.74.1.773-776.2006","article-title":"Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen","volume":"74","author":"Polley","year":"2006","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib39","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1172\/JCI41281","article-title":"Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune\u2010dependent chemotherapy against experimental leishmaniasis in mice","volume":"120","author":"Dalton","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib40","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1586\/eri.10.64","article-title":"Immunomodulators: use in combined therapy against leishmaniasis","volume":"8","author":"Dalton","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib41","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/infdis\/173.4.1041","article-title":"Models of relapse of experimental visceral leishmaniasis","volume":"173","author":"Murray","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib42","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1371\/journal.pntd.0000313","article-title":"Complexities of assessing the disease burden attributable to leishmaniasis","volume":"2","author":"Bern","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib43","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1371\/journal.pntd.0000114","article-title":"Measuring the burden of neglected tropical diseases: the global burden of disease framework","volume":"1","author":"Mathers","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib44","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.1371\/journal.pntd.0000818","article-title":"Cost\u2010Effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent","volume":"4","author":"Meheus","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"suppl 2","key":"10.1111\/j.1469-0691.2011.03610.x_bib45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-3156.2010.02516.x","article-title":"The economic impact of visceral leishmaniasis on rural households in one endemic district of Bihar, India","volume":"15","author":"Sarnoff","year":"2010","journal-title":"Trop Med Int Health"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib46","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","article-title":"Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis","volume":"23","author":"Khamesipour","year":"2005","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib47","first-page":"377","article-title":"Effectiveness of leishmanization in the control of cutaneous leishmaniasis","volume":"76","author":"Nadim","year":"1983","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib48","first-page":"623","article-title":"Current status and perspectives of the immunotherapy of leishmaniasis","volume":"11","author":"El\u2010On","year":"2009","journal-title":"Isr Med Assoc J"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib49","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2217\/imt.09.40","article-title":"Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature","volume":"1","author":"Okwor","year":"2009","journal-title":"Immunotherapy"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib50","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1086\/507708","article-title":"Immunotherapy for drug\u2010refractory mucosal leishmaniasis","volume":"194","author":"Badaro","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib51","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1016\/j.vaccine.2010.04.109","article-title":"Serine proteases ofLeishmania amazonensis as immunomodulatory and disease\u2010aggravating components of the crude LaAg vaccine","volume":"28","author":"de Matos Guedes","year":"2010","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib52","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.vaccine.2010.07.063","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH\u2010F1\u2003+\u2003MPL\u2010SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis","volume":"28","author":"Nascimento","year":"2010","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib53","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1128\/IAI.70.6.2828-2836.2002","article-title":"Vaccination with plasmid DNA encoding TSA\/LmSTI1 leishmanial fusion proteins confers protection againstLeishmania major infection in susceptible BALB\/c mice","volume":"70","author":"Campos\u2010Neto","year":"2002","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib54","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.vaccine.2008.01.026","article-title":"Evaluation of an immunochemotherapeutic protocol constituted of N\u2010methyl meglumine antimoniate (Glucantime) and the recombinant Leish\u2010110f\u2003+\u2003MPL\u2010SE vaccine to treat canine visceral leishmaniasis","volume":"26","author":"Miret","year":"2008","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib55","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage\u2010regulated surface protein fromLeishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"Stager","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib56","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.vaccine.2007.05.010","article-title":"Immunization with H1, HASPB1 and MMLLeishmania proteins in a vaccine trial against experimental canine leishmaniasis","volume":"25","author":"Moreno","year":"2007","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2006.05.001","article-title":"Leishmune vaccine: the newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission\u2010blocking vaccine","volume":"141","author":"Dantas\u2010Torres","year":"2006","journal-title":"Vet Parasitol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib58","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"FML vaccine against canine visceral leishmaniasis: from second\u2010generation to synthetic vaccine","volume":"7","author":"Palatnik\u2010de\u2010Sousa","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib59","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala\u2010azar using the FML\u2010QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN)","volume":"20","author":"Borja\u2010Cabrera","year":"2002","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib60","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.vaccine.2009.09.071","article-title":"Immunotherapy with the saponin enriched\u2010Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis","volume":"28","author":"Borja\u2010Cabrera","year":"2010","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib61","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML\u2010vaccine","volume":"22","author":"Borja\u2010Cabrera","year":"2004","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib62","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.vaccine.2005.05.011","article-title":"Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence ofLeishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs","volume":"23","author":"Nogueira","year":"2005","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib63","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.vaccine.2005.11.061","article-title":"The FML\u2010vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine","volume":"24","author":"Saraiva","year":"2006","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib64","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.vaccine.2008.02.044","article-title":"Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T\u2010cells support their high\u2010quality immunogenic potential against canine visceral leishmaniasis","volume":"26","author":"Araujo","year":"2008","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib65","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.vaccine.2008.11.104","article-title":"T\u2010cell\u2010derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti\u2010Leishmania chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune","volume":"27","author":"Araujo","year":"2009","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib66","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1016\/j.vaccine.2009.05.032","article-title":"ISCOMs and ISCOMATRIX","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib67","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1371\/journal.pntd.0000866","article-title":"Adaptive immunity againstLeishmania nucleoside hydrolase maps its c\u2010terminal domain as the target of the CD4+ T cell\u2010driven protective response","volume":"4","author":"Nico","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib68","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin\u201010 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nylen","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2008.10.310","article-title":"Cytokine profiles in canine visceral leishmaniasis","volume":"128","author":"Carrillo","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib70","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nm933","article-title":"Natural antibodies and complement are endogenous adjuvants for vaccine\u2010induced CD8+ T\u2010cell responses","volume":"9","author":"Stager","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib71","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected withLeishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"J Exp Med"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib72","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1128\/IAI.00944-07","article-title":"Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T\u2010lymphocyte response with concomitant suppression of interleukin\u201010 (IL\u201010) but not IL\u20104 or IL\u201013","volume":"75","author":"Basu","year":"2007","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nm0103-99","article-title":"Can needle\u2010free administration of vaccines become the norm in global immunization?","volume":"9","author":"Levine","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/hv.6.1.10116","article-title":"Prime\u2010boost vectored malaria vaccines: progress and prospects","volume":"6","author":"Hill","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib75","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.vaccine.2010.11.050","article-title":"Evaluation of a prototype dengue\u20101 DNA vaccine in a Phase 1 clinical trial","volume":"29","author":"Beckett","year":"2010","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2010.12.058","article-title":"The PEDVAC trial: preliminary data from the first therapeutic DNA vaccination in HIV\u2010infected children","author":"Palma","year":"2011","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib77","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine\u2010mediated protection againstLeishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib78","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.20092532","article-title":"IL\u201010 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform","volume":"207","author":"Darrah","year":"2010","journal-title":"J Exp Med"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib79","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.vaccine.2008.11.094","article-title":"A prime\/boost DNA\/Modified vaccinia virus Ankara vaccine expressing recombinantLeishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis","volume":"27","author":"Carson","year":"2009","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.vaccine.2007.11.021","article-title":"Heterologous prime\u2010boost vaccination with a non\u2010replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1\u2010specific immune response","volume":"26","author":"Ramos","year":"2008","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib81","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.micinf.2005.10.004","article-title":"MVA\u2010LACK as a safe and efficient vector for vaccination against leishmaniasis","volume":"8","author":"Perez\u2010Jimenez","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib82","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.166.8.5122","article-title":"The potency and durability of DNA\u2010 and protein\u2010based vaccines againstLeishmania major evaluated using low\u2010dose, intradermal challenge","volume":"166","author":"Mendez","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1098\/rstb.2001.0985","article-title":"From genomes to vaccines:Leishmania as a model","volume":"357","author":"Almeida","year":"2002","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib84","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2005.12.012","article-title":"From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murineLeishmania major infection","volume":"24","author":"Stober","year":"2006","journal-title":"Vaccine"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib85","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1128\/IAI.72.8.4924-4928.2004","article-title":"DNA\u2010Salmonella enterica serovar Typhimurium primer\u2010booster vaccination biases towards T helper 1 responses and enhances protection againstLeishmania major infection in mice","volume":"72","author":"Lange","year":"2004","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib86","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/IAI.65.1.171-178.1997","article-title":"Vaccine efficacy ofSalmonella strains expressing glycoprotein 63 with different promoters","volume":"65","author":"McSorley","year":"1997","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib87","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.145.7.2281","article-title":"OralSalmonella typhimurium (AroA\u2010) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis","volume":"145","author":"Yang","year":"1990","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib88","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","article-title":"LeIF: a recombinantLeishmania protein that induces an IL\u201012\u2010mediated Th1 cytokine profile","volume":"161","author":"Skeiky","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib89","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1128\/IAI.00101-06","article-title":"Cloning, characterization, and serodiagnostic evaluation ofLeishmania infantum tandem repeat proteins","volume":"74","author":"Goto","year":"2006","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib90","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.181.4.1527","article-title":"A recombinantLeishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1\u2010type cytokine profile and to produce interleukin 12","volume":"181","author":"Skeiky","year":"1995","journal-title":"J Exp Med"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib91","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/jimmunol.166.1.498","article-title":"Identification and characterization of T cell\u2010stimulating antigens fromLeishmania by CD4 T cell expression cloning","volume":"166","author":"Probst","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib92","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protectiveLeishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib93","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.182.5.1423","article-title":"Cloning and expression of aLeishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages","volume":"182","author":"Campos\u2010Neto","year":"1995","journal-title":"J Exp Med"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib94","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.1112680","article-title":"The genome of the kinetoplastid parasite,Leishmania major","volume":"309","author":"Ivens","year":"2005","journal-title":"Science"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib95","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1096\/fj.07-9254com","article-title":"RetoolingLeishmania metabolism: from sand fly gut to human macrophage","volume":"22","author":"Rosenzweig","year":"2008","journal-title":"FASEB J"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib96","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1074\/mcp.M700343-MCP200","article-title":"Transgenic, fluorescentLeishmania mexicana allow direct analysis of the proteome of intracellular amastigotes","volume":"7","author":"Paape","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib97","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molbiopara.2009.10.009","article-title":"Gel free analysis of the proteome of intracellularLeishmania mexicana","volume":"169","author":"Paape","year":"2010","journal-title":"Mol Biochem Parasitol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib98","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr Opin Microbiol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib99","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1128\/IAI.01205-06","article-title":"Bioinformatic identification of tandem repeat antigens of theLeishmania donovani complex","volume":"75","author":"Goto","year":"2007","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib100","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1128\/IAI.68.3.1328-1336.2000","article-title":"Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants","volume":"68","author":"Aebischer","year":"2000","journal-title":"Infect Immun"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib101","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/eji.1830261248","article-title":"Antigen presentation byLeishmania mexicana\u2010infected macrophages: activation of helper T cells by a model parasite antigen secreted into the parasitophorous vacuole or expressed on the amastigote surface","volume":"26","author":"Wolfram","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib102","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.4049\/jimmunol.176.8.4826","article-title":"In vivo recognition of ovalbumin expressed by transgenicLeishmania is determined by its subcellular localization","volume":"176","author":"Prickett","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib103","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0169-4758(99)01473-8","article-title":"Antigen presentation by macrophages harboring intravesicular pathogens","volume":"15","author":"Overath","year":"1999","journal-title":"Parasitol Today"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib104","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2164-9-2","article-title":"Codon usage suggests that translational selection has a major impact on protein expression in trypanosomatids","volume":"9","author":"Horn","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.molbiopara.2005.12.009","article-title":"Expression profiling by whole\u2010genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion\u2010derived amastigotes, and axenic amastigotes in Leishmania mexicana","volume":"146","author":"Holzer","year":"2006","journal-title":"Mol Biochem Parasitol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.molbiopara.2006.11.009","article-title":"Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: theLeishmania genome is constitutively expressed","volume":"152","author":"Leifso","year":"2007","journal-title":"Mol Biochem Parasitol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib107","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1096\/fj.10-157529","article-title":"Multiple levels of gene regulation mediate differentiation of the intracellular pathogenLeishmania","volume":"25","author":"Lahav","year":"2011","journal-title":"FASEB J"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib108","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1128\/IAI.67.11.5559-5566.1999","article-title":"Control of Leishmania infantum infection is associated with CD8+ and gamma interferon\u2010 and interleukin\u20105\u2010producing CD4+ antigen\u2010specific T cells","volume":"67","author":"Mary","year":"1999","journal-title":"Infect Immun"},{"issue":"suppl 12","key":"10.1111\/j.1469-0691.2011.03610.x_bib109","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1186\/1471-2105-9-S12-S22","article-title":"Evaluation of MHC\u2010II peptide binding prediction servers: applications for vaccine research","volume":"9","author":"Lin","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1034\/j.1399-0039.2003.00112.x","article-title":"Sensitive quantitative predictions of peptide\u2010MHC binding by a \u2018Query by Committee\u2019 artificial neural network approach","volume":"62","author":"Buus","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib111","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1110\/ps.0239403","article-title":"Reliable prediction of T\u2010cell epitopes using neural networks with novel sequence representations","volume":"12","author":"Nielsen","year":"2003","journal-title":"Protein Sci"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-005-0009-9","article-title":"The Indian Genome Variation database (IGVdb): a project overview","volume":"118","year":"2005","journal-title":"Hum Genet"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib113","first-page":"423","article-title":"From genomes to vaccines for leishmaniasis","volume":"270","author":"Stober","year":"2004","journal-title":"Methods Mol Biol"},{"key":"10.1111\/j.1469-0691.2011.03610.x_bib114","doi-asserted-by":"crossref","first-page":"e1000484","DOI":"10.1371\/journal.ppat.1000484","article-title":"Vector transmission of leishmania abrogates vaccine\u2010induced protective immunity","volume":"5","author":"Peters","year":"2009","journal-title":"PLoS Pathog"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14618607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14618607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T14:50:11Z","timestamp":1686149411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14618607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":114,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1198743X14618607"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03610.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}